Pier Capital, LLC Veracyte, Inc. Transaction History

Pier Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $2.95 Million - $4.26 Million	-142,184 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$23.87 - $30.93 $1,479 - $1,917	62 Added 0.04%	142,184 $3.41 Million
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $1.39 Million - $1.8 Million	-63,098 Reduced 30.75%	142,122 $4.05 Million
Q1 2019 Apr 24, 2019	SELL	$12.0 - $25.76 $2 Million - $4.3 Million	-166,829 Reduced 44.84%	205,220 $5.14 Million
Q4 2018 Feb 13, 2019	SELL	$9.15 - $14.85 $2.47 Million - $4.01 Million	-269,808 Reduced 42.04%	372,049 $4.68 Million
Q3 2018 Nov 14, 2018	BUY	$9.55 - $12.64 $6.13 Million - $8.11 Million	641,857 New	641,857 $6.13 Million

338

80.4M

212K

18.5K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.17B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pier Capital, LLC with notifications on news.